Sun Pharmaceutical Industries Inc recalls Spironolactone Tablets
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Presence of foreign substance: identified as aluminum.
- Products
-
- Spironolactone Tablets
- Where it was sold
-
USA Nationwide
Nationwide
- Units affected
- 11,328 bottles
- About this recall
- Spironolactone Tablets, USP, 25 mg, 100-count bottle, Rx only, Mfg. by: Frontida BioPharm, Inc., 1100 Orthodox St, Philadelphia, PA 19124, Dist. by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 53489-143-01